B-Soft Co Ltd (300451) - Net Assets

Latest as of March 2026: CN¥4.00 Billion CNY ≈ $585.00 Million USD

Based on the latest financial reports, B-Soft Co Ltd (300451) has net assets worth CN¥4.00 Billion CNY (≈ $585.00 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.12 Billion ≈ $749.01 Million USD) and total liabilities (CN¥1.12 Billion ≈ $164.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 300451 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥4.00 Billion
% of Total Assets 78.1%
Annual Growth Rate 23.31%
5-Year Change -11.44%
10-Year Change 438.53%
Growth Volatility 45.86

B-Soft Co Ltd - Net Assets Trend (2011–2025)

This chart illustrates how B-Soft Co Ltd's net assets have evolved over time, based on quarterly financial data. See 300451 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for B-Soft Co Ltd (2011–2025)

The table below shows the annual net assets of B-Soft Co Ltd from 2011 to 2025. For live valuation and market cap data, see B-Soft Co Ltd market cap and net worth.

Year Net Assets Change
2025-12-31 CN¥4.07 Billion
≈ $596.02 Million
-8.95%
2024-12-31 CN¥4.47 Billion
≈ $654.61 Million
-4.08%
2023-12-31 CN¥4.66 Billion
≈ $682.47 Million
+1.35%
2022-12-31 CN¥4.60 Billion
≈ $673.39 Million
+0.05%
2021-12-31 CN¥4.60 Billion
≈ $673.02 Million
+10.12%
2020-12-31 CN¥4.18 Billion
≈ $611.19 Million
+59.09%
2019-12-31 CN¥2.63 Billion
≈ $384.18 Million
+11.34%
2018-12-31 CN¥2.36 Billion
≈ $345.05 Million
+13.81%
2017-12-31 CN¥2.07 Billion
≈ $303.17 Million
+173.93%
2016-12-31 CN¥756.34 Million
≈ $110.68 Million
+26.20%
2015-12-31 CN¥599.31 Million
≈ $87.70 Million
+73.79%
2014-12-31 CN¥344.85 Million
≈ $50.46 Million
+12.30%
2013-12-31 CN¥307.08 Million
≈ $44.94 Million
+17.82%
2012-12-31 CN¥260.64 Million
≈ $38.14 Million
+20.29%
2011-12-31 CN¥216.67 Million
≈ $31.71 Million
--

Equity Component Analysis

This analysis shows how different components contribute to B-Soft Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 725.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥811.57 Million 20.24%
Other Components CN¥3.20 Billion 79.76%
Total Equity CN¥4.01 Billion 100.00%

B-Soft Co Ltd Competitors by Market Cap

The table below lists competitors of B-Soft Co Ltd ranked by their market capitalization.

Company Market Cap
Shenandoah Telecommunications Co
NASDAQ:SHEN
$784.47 Million
Shanghai Ganglian E Commerce
SHE:300226
$784.47 Million
Sana Biotechnology Inc
NASDAQ:SANA
$784.78 Million
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
$785.07 Million
Wushang Group Co Ltd
SHE:000501
$784.32 Million
Salfacorp
SN:SALFACORP
$784.10 Million
Omnijoi Media Corp
SHE:300528
$784.06 Million
Sichuan Jiuyuan Yinhai Software Co Ltd
SHE:002777
$783.75 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in B-Soft Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 4,419,247,940 to 4,010,036,186, a change of -409,211,754 (-9.3%).
  • Net loss of 401,653,590 reduced equity.
  • Dividend payments of 344,619 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥-401.65 Million -10.02%
Dividends Paid CN¥344.62K -0.01%
Other Changes CN¥-7.21 Million -0.18%
Total Change CN¥- -9.26%

Book Value vs Market Value Analysis

This analysis compares B-Soft Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.34x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 14.06x to 1.34x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2011-12-31 CN¥0.25 CN¥3.46 x
2012-12-31 CN¥0.29 CN¥3.46 x
2013-12-31 CN¥0.34 CN¥3.46 x
2014-12-31 CN¥0.38 CN¥3.46 x
2015-12-31 CN¥0.56 CN¥3.46 x
2016-12-31 CN¥0.61 CN¥3.46 x
2017-12-31 CN¥1.49 CN¥3.46 x
2018-12-31 CN¥1.62 CN¥3.46 x
2019-12-31 CN¥1.82 CN¥3.46 x
2020-12-31 CN¥2.70 CN¥3.46 x
2021-12-31 CN¥2.96 CN¥3.46 x
2022-12-31 CN¥3.23 CN¥3.46 x
2023-12-31 CN¥2.51 CN¥3.46 x
2024-12-31 CN¥2.86 CN¥3.46 x
2025-12-31 CN¥2.59 CN¥3.46 x

Capital Efficiency Dashboard

This dashboard shows how efficiently B-Soft Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -10.02%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -38.19%
  • • Asset Turnover: 0.20x
  • • Equity Multiplier: 1.32x
  • Recent ROE (-10.02%) is below the historical average (7.91%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 21.77% 14.01% 1.06x 1.46x CN¥25.50 Million
2012 16.90% 12.20% 0.98x 1.41x CN¥17.99 Million
2013 14.93% 12.10% 0.84x 1.46x CN¥15.09 Million
2014 13.83% 11.73% 0.82x 1.44x CN¥13.16 Million
2015 8.30% 11.66% 0.48x 1.48x CN¥-10.18 Million
2016 8.69% 11.48% 0.48x 1.56x CN¥-9.48 Million
2017 8.01% 14.16% 0.43x 1.32x CN¥-40.55 Million
2018 9.16% 16.48% 0.42x 1.33x CN¥-19.43 Million
2019 12.13% 21.22% 0.41x 1.39x CN¥55.10 Million
2020 8.03% 20.35% 0.31x 1.27x CN¥-81.63 Million
2021 9.05% 21.75% 0.34x 1.23x CN¥-43.14 Million
2022 0.93% 2.79% 0.26x 1.26x CN¥-416.74 Million
2023 0.80% 2.27% 0.28x 1.26x CN¥-423.91 Million
2024 -3.93% -12.20% 0.25x 1.28x CN¥-615.45 Million
2025 -10.02% -38.19% 0.20x 1.32x CN¥-802.66 Million

Industry Comparison

This section compares B-Soft Co Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $520,489,114
  • Average return on equity (ROE) among peers: -1.75%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
B-Soft Co Ltd (300451) CN¥4.00 Billion 21.77% 0.28x $784.33 Million
Vanfund Urban Investment & Development Co Ltd (000638) $310.70 Million -11.39% 7.17x $40.55 Million
Shanghai Kingstar Winning Software (300253) $53.30 Million 31.93% 0.38x $2.30 Billion
Longmaster Information Tech (300288) $1.10 Billion -46.73% 0.21x $463.85 Million
Heren Health Co Ltd (300550) $42.53 Million 0.00% 0.59x $574.39 Million
Yarward Electronics Shandong Co. Ltd. A (301337) $1.15 Billion 3.97% 0.13x $441.27 Million
Suzhou Medsys Tech Co Ltd (603990) $473.16 Million 11.73% 0.52x $977.50 Million

About B-Soft Co Ltd

SHE:300451 China Health Information Services
Market Cap
$784.33 Million
CN¥5.36 Billion CNY
Market Cap Rank
#10156 Global
#2734 in China
Share Price
CN¥3.46
Change (1 day)
-0.29%
52-Week Range
CN¥3.46 - CN¥6.63
All Time High
CN¥281.72
About

B-SOFT Co.,Ltd. operates in the healthcare information technology industry in China. The company offers Huikang·Yunshu Intelligent Body, a medical AI agent of Huikang. It also provides outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and hospital cloud platform; and big data and artificial intelligence, hospital-wide medical… Read more